2011
DOI: 10.1007/s00428-011-1170-2
|View full text |Cite
|
Sign up to set email alerts
|

CD99 is expressed in chordoid glioma and suggests ependymal origin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
6
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 15 publications
1
6
0
Order By: Relevance
“…It is recognized to occur in “primary neuroepithelial tumors of the kidney,” an entity we believe to be closely related to ATRT (24). It is also present in ependymoma, peripheral primitive neuroectodermal tumor, and in the rare chordoid glioma, all of which are of neuroepithelial origin (25–27). …”
Section: Resultsmentioning
confidence: 99%
“…It is recognized to occur in “primary neuroepithelial tumors of the kidney,” an entity we believe to be closely related to ATRT (24). It is also present in ependymoma, peripheral primitive neuroectodermal tumor, and in the rare chordoid glioma, all of which are of neuroepithelial origin (25–27). …”
Section: Resultsmentioning
confidence: 99%
“… Author (year) # of patients Average Age Extent of Resection (initial tumor) Reported # that underwent radiotherapy† Reported patient recurrences Reported deaths Al-Zubidi et al (2014)[41]137STR000Kobayashi et al (2013)[47]349Bx (n=2)STR (n=1)301Ni et al (2013)[18]440GTR (n=4)000Shiramizu et al (2013)[54]149GTR000Scheurkogel et al (2012)[55]130STR000Romero-Rojas et al (2012)[14]139GTR000Can et al (2012)[38]137
…”
Section: Resultsmentioning
confidence: 99%
“…For those patients who did have progression, specifically within the STR group, time to progression ranged from 4 months to 4 years. The limited follow up for select patients undergoing GTR[7, 13, 14, 21, 38, 39, 41, 50, 53] may have precluded detection of later recurrences.…”
Section: Discussionmentioning
confidence: 99%
“…Immunohistochemically, strong diffuse reactivity for GFAP distinguish chordoid glioma from its mimics. The other antibodies that reported to be positive in chordoid glioma are vimentin, S-100 protein, EMA, D2-40, CD34 and CD99 (6,7,9). Rare positivity to neurofilament protein, synaptophysin and p53 are also noted (6).…”
Section: Discussionmentioning
confidence: 93%
“…The ependymal nature of chordoid glioma has been suggested by findings on electron microscopy and positivity to EMA, D2-40, and CD99 (7,9). Ultrastructurally, the tumor exhibits features of ependymal differentiation which include intermediate filaments, intercellular lumina apical microvilli, hemidesmosomes, and basal lamina (2).…”
Section: Discussionmentioning
confidence: 97%